Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71:209–49.

Valerio M, Cerantola Y, Eggener SE, Lepor H, Polascik TJ, Villers A, et al. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review. Eur Urol 2017;71:17–34.

Article  PubMed  Google Scholar 

Ploussard G, Fiard G, Barret E, Brureau L, Créhange G, Dariane C, et al. French AFU Cancer Committee Guidelines - Update 2022-2024: prostate cancer - Diagnosis and management of localised disease. Prog Urol. 2022;32:1275–372.

Article  CAS  PubMed  Google Scholar 

Cornford P, van den Bergh RCN, Briers E, Van den Broeck T, Brunckhorst O, Darraugh J, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2024;86:148–63.

Huber PM, Afzal N, Arya M, Boxler S, Dudderidge T, Emberton M, et al. Prostate Specific Antigen Criteria to Diagnose Failure of Cancer Control following Focal Therapy of Nonmetastatic Prostate Cancer Using High Intensity Focused Ultrasound. J Urol. 2020;203:734–42.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.

Article  PubMed  PubMed Central  Google Scholar 

Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155:529–36.

Article  PubMed  Google Scholar 

Freeman MF, Tukey JW. Transformations Related to the Angular and the Square Root. Ann Math Stat. 1950;21:607–11.

Article  Google Scholar 

Deeks JJ, Altman DG, Bradburn MJ. Statistical Methods for Examining Heterogeneity and Combining Results from Several Studies in Meta‐Analysis. 2024; Available from: https://onlinelibrary.wiley.com/doi/10.1002/9780470693926.ch15.

Wang N. Conducting Meta-analyses of Proportions in R. J Behav Data Sci. 2023;3:64–126.

Article  Google Scholar 

Tay KJ, Schulman AA, Sze C, Tsivian E, Polascik TJ. New advances in focal therapy for early stage prostate cancer. Expert Rev Anticancer Ther. 2017;17:737–43.

Article  CAS  PubMed  Google Scholar 

Dickinson L, Ahmed HU, Hindley RG, McCartan N, Freeman A, Allen C, et al. Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urol Oncol. 2017;35:30.e9–30.e15.

Article  CAS  PubMed  Google Scholar 

von Hardenberg J, Westhoff N, Baumunk D, Hausmann D, Martini T, Marx A, et al. Prostate cancer treatment by the latest focal HIFU device with MRI/TRUS-fusion control biopsies: A prospective evaluation. Urol Oncol. 2018;36:401.e1–401.e9.

Article  Google Scholar 

Lotte R, Lafourcade A, Mozer P, Conort P, Barret E, Comperat E, et al. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed? Eur Radiol. 2018;28:3760–9.

Article  PubMed  Google Scholar 

Rosenhammer B, Niessen C, Rotzinger L, Reiss J, Schnabel MJ, Burger M, et al. Oncological Outcome and Value of Postoperative Magnetic Resonance Imaging after Focal High-Intensity Focused Ultrasound Therapy for Prostate Cancer. Urol Int. 2019;103:270–8.

Article  CAS  PubMed  Google Scholar 

Bass R, Fleshner N, Finelli A, Barkin J, Zhang L. Klotz L. Oncologic and Functional Outcomes of Partial Gland Ablation with High Intensity Focused Ultrasound for Localized Prostate Cancer. J Urol. 2019;201:113–9.

Article  PubMed  Google Scholar 

Mortezavi A, Krauter J, Gu A, Sonderer J, Bruhin J, Reeve KA, et al. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound. J Urol. 2019;202:717–24.

Article  PubMed  Google Scholar 

Shoji S, Hiraiwa S, Uemura K, Nitta M, Hasegawa M, Kawamura Y, et al. Focal therapy with high-intensity focused ultrasound for the localized prostate cancer for Asian based on the localization with MRI-TRUS fusion image-guided transperineal biopsy and 12-cores transperineal systematic biopsy: prospective analysis of oncological and functional outcomes. Int J Clin Oncol. 2020;25:1844–53.

Article  CAS  PubMed  Google Scholar 

Bacchetta F, Martins M, Regusci S, Jichlinski P, Meuwly JY, Lucca I, et al. The utility of intraoperative contrast-enhanced ultrasound in detecting residual disease after focal HIFU for localized prostate cancer. Urol Oncol. 2020;38:846.e1–846.e7.

Article  PubMed  Google Scholar 

Rompré-Brodeur A, Marcq G, Tholomier C, Fugaru I, Loutochin O, Anidjar M, et al. Role of Systematic Control Biopsies following Partial Gland Ablation with High-Intensity Focused Ultrasound for Clinically Significant Prostate Cancer. J Urol. 2021;206:1177–83.

Article  PubMed  Google Scholar 

Yee CH, Chiu PKF, Teoh JYC, Ng CF, Chan CK, Hou SM. High-Intensity Focused Ultrasound (HIFU) Focal Therapy for Localized Prostate Cancer with MRI-US Fusion Platform. Adv Urol. 2021;2021:7157973.

Article  PubMed  PubMed Central  Google Scholar 

Ahn H, Hwang SI, Lee HJ, Kim SY, Cho JY, Lee H, et al. Diagnostic performance of MRI for prediction of recurrent prostate cancer after high-intensity focused ultrasound: a systematic review and meta-analysis. Prostate Int. 2023;11:59–68.

Article  PubMed  Google Scholar 

Khandwala YS, Morisetty S, Ghanouni P, Fan RE, Soerensen SJC, Rusu M, et al. Evaluation of post-ablation mpMRI as a predictor of residual prostate cancer after focal high intensity focused ultrasound (HIFU) ablation. Urol Oncol. 2022;40:489.e9–489.e17.

Article  PubMed  Google Scholar 

Pausch AM, Elsner C, Rupp NJ, Eberli D, Hötker AM. MRI-based monitoring of prostate cancer after HIFU: Inter-reader agreement and diagnostic performance of the PI-FAB score. Eur J Radiol. 2024;175:111463.

Article  PubMed  Google Scholar 

Dellabella M, Branchi A, Di Rosa M, Pucci M, Gasparri L, Claudini R, et al. Oncological and functional outcome after partial prostate HIFU ablation with Focal-One®: a prospective single-center study. Prostate Cancer Prostatic Dis. 2021;24:1189–97.

Article  CAS  PubMed  Google Scholar 

Giganti F, Dickinson L, Orczyk C, Haider A, Freeman A, Emberton M, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629–34.

Article  PubMed  Google Scholar 

Light A, Mayor N, Cullen E, Kirkham A, Padhani AR, Arya M, et al. The Transatlantic Recommendations for Prostate Gland Evaluation with Magnetic Resonance Imaging After Focal Therapy (TARGET): A Systematic Review and International Consensus Recommendations. Eur Urol. 2024;85:466–82.

Article  PubMed  Google Scholar 

Barentsz JO, Weinreb JC, Verma S, Thoeny HC, Tempany CM, Shtern F, et al. Synopsis of the PI-RADS v2 Guidelines for Multiparametric Prostate Magnetic Resonance Imaging and Recommendations for Use. Eur Urol. 2016;69:41–9.

Article  PubMed  Google Scholar 

Panebianco V, Villeirs G, Weinreb JC, Turkbey BI, Margolis DJ, Richenberg J, et al. Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy. Eur Urol Oncol 2021;4:868–76.

Article  PubMed  Google Scholar